Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $30.36 USD
Change Today -0.25 / -0.82%
Volume 296.6K
EBS On Other Exchanges
Symbol
Exchange
Berlin
New York
As of 4:15 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - EMERGENT BIOSOLUTIONS INC (EBS)

Emergent BioSolutions, Inc. to Report Q4, 2014 on Mar 05, 2015
CapIQ 03/05/2015 9:01 PM ET
Emergent BioSolutions, Inc. to Report Q3, 2014 on Nov 06, 2014
CapIQ 03/05/2015 9:01 PM ET
Emergent BioSolutions, Inc. to Report Q2, 2014 on Aug 07, 2014
CapIQ 03/05/2015 9:01 PM ET

2013 revenues at Emergent BioSolutions, Inc. totaled $312.7M USD, while annual earnings equaled $0.99 per share.

Quarterly Earnings & Estimates - EMERGENT BIOSOLUTIONS INC (EBS)

Actuals vs. Estimates for EMERGENT BIOSOLUTIONS INC EBS

Emergent BioSolutions, Inc.'s Quarterly Earnings

Emergent BioSolutions, Inc. reported 1st quarter 2014 losses of $0.40 per share on 05/10/2014.

Annual Earnings & Estimates - EMERGENT BIOSOLUTIONS INC (EBS)

Actuals vs. Estimates for EMERGENT BIOSOLUTIONS INC EBS

Emergent BioSolutions, Inc.'s Annual Earnings

Emergent BioSolutions, Inc. reported annual 2013 earnings of $0.99 per share on 03/8/2014.

Quarterly Revenues - EMERGENT BIOSOLUTIONS INC (EBS)

Actuals vs. Estimates for EMERGENT BIOSOLUTIONS INC EBS

Emergent BioSolutions, Inc.'s Quarterly Revenues

Emergent BioSolutions, Inc. had 1st quarter 2014 revenues of $53.9M USD. This missed the $57.3M USD consensus estimate of the 2 analysts following the company. This was 25.0% above the prior year's 1st quarter results.

Annual Revenues - EMERGENT BIOSOLUTIONS INC (EBS)

Actuals vs. Estimates for EMERGENT BIOSOLUTIONS INC EBS

Emergent BioSolutions, Inc.'s Annual Revenues

Emergent BioSolutions, Inc. had revenues for the full year 2013 of $312.7M USD. This was 10.9% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EBS:US $30.36 USD -0.25

EBS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Albany Molecular Research Inc $18.99 USD -0.09
Chimerix Inc $37.53 USD -1.95
Depomed Inc $25.77 USD -1.87
Nektar Therapeutics $10.56 USD -0.21
Skyepharma PLC 321.00 GBp +0.50
View Industry Companies
 

Industry Analysis

EBS

Industry Average

Valuation EBS Industry Range
Price/Earnings 38.2x
Price/Sales 2.6x
Price/Book 2.1x
Price/Cash Flow 31.9x
TEV/Sales 1.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EMERGENT BIOSOLUTIONS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.